Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Essential Role for Epidermal Growth Factor Receptor in Glutamate Receptor Signaling to NF-B
Raquel Sitcheran,1*
William C. Comb,1,2
Patricia C. Cogswell,1, and
Albert S. Baldwin1,2,3*
Lineberger Comprehensive Cancer Center,1
Curriculum in Genetics and Molecular Biology,2
Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 275993
Received for publication 9 April 2008.
Revision received 21 May 2008.
Accepted for publication 27 May 2008.
Abstract:
Glutamate is a critical neurotransmitter of the central nervoussystem (CNS) and also an important regulator of cell survivaland proliferation. The binding of glutamate to metabotropicglutamate receptors induces signal transduction cascades thatlead to gene-specific transcription. The transcription factorNF-B, which regulates cell proliferation and survival, is activatedby glutamate; however, the glutamate receptor-induced signalingpathways that lead to this activation are not clearly defined.Here we investigate the glutamate-induced activation of NF-Bin glial cells of the CNS, including primary astrocytes. Weshow that glutamate induces phosphorylation, nuclear accumulation,DNA binding, and transcriptional activation function of glialp65. The glutamate-induced activation of NF-B requires calcium-dependentIB kinase (IKK) and IKKβ activation and induces p65-IBdissociation in the absence of IB phosphorylation or degradation.Moreover, glutamate-induced IKK preferentially targets the phosphorylationof p65 but not IB. Finally, we show that the ability of glutamateto activate NF-B requires cross-coupled signaling with the epidermalgrowth factor receptor. Our results provide insight into a glutamate-inducedregulatory pathway distinct from that described for cytokine-inducedNF-B activation and have important implications with regardto both normal glial cell physiology and pathogenesis.
* Corresponding author. Mailing address for Albert S. Baldwin: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, CB#7295, Chapel Hill, NC 27599-7295. Phone: (919) 966-3652. Fax: (919) 966-0444. E-mail: asbaldwin{at}med.unc.edu. Mailing address for Raquel Sitcheran: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, 450 West Drive, CB#7295, Chapel Hill, NC 27599-7295. Phone: (919) 966-3884. Fax: (919) 966-8212. E-mail: sitcheran{at}unc.edu
Published ahead of print on 9 June 2008.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
John F. Foley (5 August 2008) Sci. Signal.1 (31), ec278.
[DOI: 10.1126/scisignal.131ec278] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Activation of NF-{kappa}B Is a Novel Target of KRAS-Induced Endometrial Carcinogenesis.
Y. Mizumoto, S. Kyo, T. Kiyono, M. Takakura, M. Nakamura, Y. Maida, N. Mori, Y. Bono, H. Sakurai, and M. Inoue (2011)
Clin. Cancer Res.
17, 1341-1350
|Abstract »|Full Text »|PDF »
Resistance to ErbB2 Tyrosine Kinase Inhibitors in Breast Cancer Is Mediated by Calcium-Dependent Activation of RelA.
W. Xia, S. Bacus, I. Husain, L. Liu, S. Zhao, Z. Liu, M. A. Moseley III, J. W. Thompson, F. L. Chen, K. M. Koch, et al. (2010)
Mol. Cancer Ther.
9, 292-299
|Abstract »|Full Text »|PDF »
Excitotoxic Death of Retinal Neurons In Vivo Occurs via a Non-Cell-Autonomous Mechanism.
F. Lebrun-Julien, L. Duplan, V. Pernet, I. Osswald, P. Sapieha, P. Bourgeois, K. Dickson, D. Bowie, P. A. Barker, and A. Di Polo (2009)
J. Neurosci.
29, 5536-5545
|Abstract »|Full Text »|PDF »